FDMT
Price
$4.64
Change
-$0.03 (-0.64%)
Updated
Feb 21 closing price
Capitalization
214.5M
36 days until earnings call
STOK
Price
$8.33
Change
-$0.41 (-4.69%)
Updated
Feb 21 closing price
Capitalization
441.21M
10 days until earnings call
Ad is loading...

FDMT vs STOK

Header iconFDMT vs STOK Comparison
Open Charts FDMT vs STOKBanner chart's image
4D Molecular Therapeutics
Price$4.64
Change-$0.03 (-0.64%)
Volume$563.37K
Capitalization214.5M
Stoke Therapeutics
Price$8.33
Change-$0.41 (-4.69%)
Volume$1.04M
Capitalization441.21M
FDMT vs STOK Comparison Chart
Loading...
FDMT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
STOK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
FDMT vs. STOK commentary
Feb 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FDMT is a Hold and STOK is a Hold.

Ad is loading...
COMPARISON
Comparison
Feb 23, 2025
Stock price -- (FDMT: $4.64 vs. STOK: $8.33)
Brand notoriety: FDMT and STOK are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: FDMT: 56% vs. STOK: 120%
Market capitalization -- FDMT: $214.5M vs. STOK: $441.21M
FDMT [@Biotechnology] is valued at $214.5M. STOK’s [@Biotechnology] market capitalization is $441.21M. The market cap for tickers in the [@Biotechnology] industry ranges from $393.7B to $0. The average market capitalization across the [@Biotechnology] industry is $2.51B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

FDMT’s FA Score shows that 0 FA rating(s) are green whileSTOK’s FA Score has 0 green FA rating(s).

  • FDMT’s FA Score: 0 green, 5 red.
  • STOK’s FA Score: 0 green, 5 red.
According to our system of comparison, STOK is a better buy in the long-term than FDMT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

FDMT’s TA Score shows that 2 TA indicator(s) are bullish while STOK’s TA Score has 4 bullish TA indicator(s).

  • FDMT’s TA Score: 2 bullish, 7 bearish.
  • STOK’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, STOK is a better buy in the short-term than FDMT.

Price Growth

FDMT (@Biotechnology) experienced а -4.92% price change this week, while STOK (@Biotechnology) price change was -22.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.71%. For the same industry, the average monthly price growth was -2.01%, and the average quarterly price growth was +0.86%.

Reported Earning Dates

FDMT is expected to report earnings on May 08, 2025.

STOK is expected to report earnings on May 12, 2025.

Industries' Descriptions

@Biotechnology (-1.71% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
STOK($441M) has a higher market cap than FDMT($214M). FDMT YTD gains are higher at: -16.697 vs. STOK (-24.479). STOK has higher annual earnings (EBITDA): -115.03M vs. FDMT (-161.94M). FDMT has more cash in the bank: 502M vs. STOK (239M). STOK has less debt than FDMT: STOK (2.3M) vs FDMT (24.8M). STOK has higher revenues than FDMT: STOK (16.7M) vs FDMT (17K).
FDMTSTOKFDMT / STOK
Capitalization214M441M49%
EBITDA-161.94M-115.03M141%
Gain YTD-16.697-24.47968%
P/E RatioN/AN/A-
Revenue17K16.7M0%
Total Cash502M239M210%
Total Debt24.8M2.3M1,079%
TECHNICAL ANALYSIS
Technical Analysis
FDMTSTOK
RSI
ODDS (%)
Bearish Trend 3 days ago
84%
Bullish Trend 3 days ago
81%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
79%
Bullish Trend 3 days ago
82%
Momentum
ODDS (%)
Bearish Trend 3 days ago
87%
Bearish Trend 3 days ago
85%
MACD
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
78%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
89%
Bearish Trend 3 days ago
85%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
Advances
ODDS (%)
Bullish Trend 10 days ago
81%
Bullish Trend 10 days ago
85%
Declines
ODDS (%)
Bearish Trend 3 days ago
89%
Bearish Trend 3 days ago
83%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
85%
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
85%
View a ticker or compare two or three
Ad is loading...
FDMT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
STOK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SREZX13.21-0.12
-0.90%
PGIM Select Real Estate Z
NQCCX3.72-0.05
-1.33%
Nuveen Large Cap Value Opportunities C
SCAVX14.26-0.35
-2.40%
AB Small Cap Value A
HCMQX19.18-0.55
-2.79%
HCM Dividend Sector Plus I
LGLVX50.87-1.90
-3.60%
Lord Abbett Growth Leaders R6

FDMT and

Correlation & Price change

A.I.dvisor indicates that over the last year, FDMT has been loosely correlated with QRON. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if FDMT jumps, then QRON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FDMT
1D Price
Change %
FDMT100%
-0.64%
QRON - FDMT
39%
Loosely correlated
N/A
ORMP - FDMT
38%
Loosely correlated
-3.15%
IMNM - FDMT
36%
Loosely correlated
-5.84%
AXON - FDMT
34%
Loosely correlated
-5.28%
STOK - FDMT
34%
Loosely correlated
-4.69%
More

STOK and

Correlation & Price change

A.I.dvisor indicates that over the last year, STOK has been loosely correlated with STRO. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if STOK jumps, then STRO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To STOK
1D Price
Change %
STOK100%
-4.69%
STRO - STOK
51%
Loosely correlated
-3.28%
QTTB - STOK
46%
Loosely correlated
+5.76%
NUVB - STOK
46%
Loosely correlated
-2.64%
ROIV - STOK
39%
Loosely correlated
-0.37%
DNLI - STOK
37%
Loosely correlated
-3.98%
More